Cost of Alzheimer's disease

The progressive deterioration associated with Alzheimer's disease (AD) results in high economic cost to the patients, caregivers, and the society as a whole. Cost-of-AD studies conducted over the last decade have produced discrepant results, mainly as a consequence of the different methodologie...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson, Michael, Schnaider Beeri, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2000
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181598/
https://www.ncbi.nlm.nih.gov/pubmed/22034387
_version_ 1782212769671544832
author Davidson, Michael
Schnaider Beeri, Michal
author_facet Davidson, Michael
Schnaider Beeri, Michal
author_sort Davidson, Michael
collection PubMed
description The progressive deterioration associated with Alzheimer's disease (AD) results in high economic cost to the patients, caregivers, and the society as a whole. Cost-of-AD studies conducted over the last decade have produced discrepant results, mainly as a consequence of the different methodologies employed. The present review is an attempt to present the methodology of the cost studies in AD and provide the reader with the tools necessary for a critical assessment of the results.
format Online
Article
Text
id pubmed-3181598
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-31815982011-10-27 Cost of Alzheimer's disease Davidson, Michael Schnaider Beeri, Michal Dialogues Clin Neurosci Clinical Research The progressive deterioration associated with Alzheimer's disease (AD) results in high economic cost to the patients, caregivers, and the society as a whole. Cost-of-AD studies conducted over the last decade have produced discrepant results, mainly as a consequence of the different methodologies employed. The present review is an attempt to present the methodology of the cost studies in AD and provide the reader with the tools necessary for a critical assessment of the results. Les Laboratoires Servier 2000-06 /pmc/articles/PMC3181598/ /pubmed/22034387 Text en Copyright: © 2000 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research
Davidson, Michael
Schnaider Beeri, Michal
Cost of Alzheimer's disease
title Cost of Alzheimer's disease
title_full Cost of Alzheimer's disease
title_fullStr Cost of Alzheimer's disease
title_full_unstemmed Cost of Alzheimer's disease
title_short Cost of Alzheimer's disease
title_sort cost of alzheimer's disease
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181598/
https://www.ncbi.nlm.nih.gov/pubmed/22034387
work_keys_str_mv AT davidsonmichael costofalzheimersdisease
AT schnaiderbeerimichal costofalzheimersdisease

Ejemplares similares